Pharmacogenetic Testing for Warfarin Advances
Pharmacogenetics has the potential to avoid some of the three quarter million adverse drug events seen each year.
Read MorePosted by Clinical Lab Products | Jul 1, 2009 | Cancer, Miscellaneous |
Pharmacogenetics has the potential to avoid some of the three quarter million adverse drug events seen each year.
Read MorePosted by Clinical Lab Products | Jun 25, 2009 | Miscellaneous |
A new article, Evaluation of Universal Antenatal Screening for Group B Streptococcus concludes that rapid, PCR-based testing at the time of admission for delivery may improve the accuracy of Group B streptococcal (GBS) screening over the normal antepartum testing done at 35-37 weeks of gestation.
Read MorePosted by Clinical Lab Products | Jun 18, 2009 | Cancer, Miscellaneous |
Health and Human Services Secretary Kathleen Sebelius today addressed the New DLC Policy Forum on Health Reform and Education Reform.
Read MorePosted by Clinical Lab Products | Jun 12, 2009 | Miscellaneous |
Illumina Inc has unveiled a service program to provide high-quality personal genome sequencing for consumers. This is the first service to offer complete coverage of the human genome sequence for under $50,000.
Read MorePosted by Clinical Lab Products | Jun 9, 2009 | Cancer, Miscellaneous |
A new study finds noninvasive blood test for liver fibrosis Mmy alleviate need for liver biopsies for some patients with chronic hepatitis C
Read More